Melanocortin 3 receptor activation with [D-Trp8]-γ-MSH suppresses inflammation in apolipoprotein E deficient mice
AffiliationUniv Arizona, Dept Chem & Biochem
MetadataShow full item record
CitationKadiri, J. J., Thapa, K., Kaipio, K., Cai, M., Hruby, V. J., & Rinne, P. (2020). Melanocortin 3 receptor activation with [D-Trp8]-γ-MSH suppresses inflammation in apolipoprotein E deficient mice. European Journal of Pharmacology, 173186. https://doi.org/10.1016/j.ejphar.2020.173186
JournalEUROPEAN JOURNAL OF PHARMACOLOGY
Rights© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractThe melanocortin MC1 and MC3 receptors elicit anti-inflammatory actions in leukocytes and activation of these receptors has been shown to alleviate arterial inflammation in experimental atherosclerosis. Thus, we aimed to investigate whether selective targeting of melanocortin MC3 receptor protects against atherosclerosis. Apolipoprotein E deficient (ApoE-/-) mice were fed high-fat diet for 12 weeks and randomly assigned to receive either vehicle (n = 11) or the selective melanocortin MC3 receptor agonist [D-Trp(8)]-gamma-melanocyte-stimulating hormone ([D-Trp8]-γ-MSH; 15 μg/day, n = 10) for the last 4 weeks. Lesion size as well as macrophage and collagen content in the aortic root plaques were determined. Furthermore, leukocyte counts in the blood and aorta and cytokine mRNA expression levels in the spleen, liver and aorta were quantified. No effect was observed in the body weight development or plasma cholesterol level between the two treatment groups. However, [D-Trp8]-γ-MSH treatment significantly reduced plasma levels of chemokine (C-C motif) ligands 2, 4 and 5. Likewise, cytokine and adhesion molecule expression levels were reduced in the spleen and liver of γ-MSH-treated mice, but not substantially in the aorta. In line with these findings, [D-Trp8]-γ-MSH treatment reduced leukocyte counts in the blood and aorta. Despite reduced inflammation, [D-Trp8]-γ-MSH did not change lesion size, macrophage content or collagen deposition of aortic root plaques. In conclusion, the findings indicate that selective activation of melanocortin MC3 receptor by [D-Trp8]-γ-MSH suppresses systemic and local inflammation and thereby also limits leukocyte accumulation in the aorta. However, the treatment was ineffective in reducing atherosclerotic plaque size.
NoteOpen access article
VersionFinal published version
- [D-Trp8]-gamma-melanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse).
- Authors: Getting SJ, Lam CW, Leoni G, Gavins FN, Grieco P, Perretti M
- Issue date: 2006 Dec
- Melanocortin 3 receptors control crystal-induced inflammation.
- Authors: Getting SJ, Lam CW, Chen AS, Grieco P, Perretti M
- Issue date: 2006 Nov
- Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
- Authors: Rinne P, Silvola JM, Hellberg S, Ståhle M, Liljenbäck H, Salomäki H, Koskinen E, Nuutinen S, Saukko P, Knuuti J, Saraste A, Roivainen A, Savontaus E
- Issue date: 2014 Jul
- Melanocortin overexpression limits diet-induced inflammation and atherosclerosis in LDLR<sup>-/-</sup> mice.
- Authors: Nuutinen S, Ailanen L, Savontaus E, Rinne P
- Issue date: 2018 Mar
- Melanocortin modulation of inflammatory cytokine and neuroendocrine responses to endotoxin in the monkey.
- Authors: Vulliémoz NR, Xiao E, Xia-Zhang L, Ferin M, Wardlaw SL
- Issue date: 2006 Apr